The importance of schedule in whole body thermochemotherapy

References

• Sakaguchi Y, Makino M, Kaneko T, Stephens LC, Strebel FR, Danhauser LL, Jenkins GN, Bull JM. Therapeutic efficacy of long duration-low temperature whole body hyperthermia when combined with tumor necrosis factor and carboplatin in rats. Cancer Res 1994; 54: 2223–2227
   PubMed Web of Science ®Google Scholar
• Ohno S, Strebel FR, Stephens LC, Siddik ZH, Baba H, Makino M, Khokhar AR, Bull JM. Haematological toxicity of carboplatin and cisplatin combined with whole body hyperthermia in rats. Br J Cancer 1993; 68: 469–474
   PubMed Web of Science ®Google Scholar
• Haveman J, Van Der Zee J, Wondergem J, Hoogeveen JF, Hulshof MC. Effects of hyperthermia on the peripheral nervous system: A review. Int J Hyperthermia 2004; 20: 371–391
   PubMed Web of Science ®Google Scholar
• Calvert AH, Harland SJ, Newell DR, Siddik, ZH, Jones AC, McElwain TJ, Raju S, Wiltshaw E, Smith IE, Baker JM, Peckham MJ, Harrap KR. Early clinical studies with cis-diammine-1,1-cyclobutane dicarboylate platinum II. Cancer Chemother Pharmacol 1982; 9: 140–147
   PubMed Web of Science ®Google Scholar
• Strebel FR, Proett JM, Rowe RW, Deng W, Bull JMC. Effect of oxaliplatin combined with fever-range whole body thermal-therapy in a rat mammary adenocarcinoma in vivo. Proc Amer Assoc Cancer Res 2006; 47: 905, (Abstract 3847)
   Google Scholar
• Baba H, Siddik ZH, Strebel FR, Jenkins GN, Bull JM. Increased therapeutic gain of combined cis-diamminedichloroplatinum (II) and whole body hyperthermia therapy by optimal heat/drug scheduling. Cancer Res 1989; 49: 7041–7044
   PubMed Web of Science ®Google Scholar
• Katschinski DM, Wiedemann GJ, Mentzel M, Mulkerin DL, Touhidi R, Robins HI. Optimization of chemotherapy administration for clinical 41.8°C whole body hyperthermia. Cancer Lett 1997; 115: 195–199
   PubMed Web of Science ®Google Scholar
• Bull JMC, Loo CH, Strebel FR, Jenkins GN, Tomoda M, Rowe RW. Treatment of a highly metastatic mammary adenocarcinoma with fever-range, long-duration, low-temperature (40°C for 6 h) whole body hyperthermia (LL-WBH) combined with gemcitabine (dFdC) in rats. Proc Amer Assoc Cancer Res 1999; 40: 552, (Abstract 3643)
   Google Scholar
• Bull JMC, Strebel FR, Jenkins GN, Tomoda M, Rowe RW. Sequence dependency of antitumor effect of gemcitabine combined with cisplatin in the highly metastatic MTLN3 rat mammary adenocarcinoma. Proc Amer Assoc Cancer Res 2000; 41: 410, (Abstract 2609)
   Google Scholar
• Evans DP, Meyn RE, Tomasovic SP. Survival of rat mammary tumor cell clones and DNA strand damage following adriamycin treatment. Cancer Chemother Pharmacol 1986; 18: 137–139
   PubMed Web of Science ®Google Scholar
• Matsuda H, Strebel FR, Kaneko T, Stephens LC, Danhauser LL, Jenkins GN, Toyota N, Bull JM. Apoptosis and necrosis occurring during different stages of primary and metastatic tumor growth of a rat mammary adenocarcinoma. Anticancer Res 1996; 16: 1117–1121
   PubMed Web of Science ®Google Scholar
• Matsuda H, Strebel FR, Kaneko T, Danhauser LL, Jenkins GN, Toyota N, Bull JM. Long duration-mild whole body hyperthermia of up to 12 hours in rats: Feasibility, and efficacy on primary tumour and axillary lymph node metastases of a mammary adenocarcinoma: Implications for adjuvant therapy. Int J Hyperthermia 1997; 13: 89–98
   PubMed Web of Science ®Google Scholar
• Baba H, Siddik ZH, Strebel FR, Jenkins GN, Bull JM. Increased therapeutic gain of combined cis-diamminedichloroplatinum (II) and whole body hyperthermia therapy by optimal heat/drug scheduling. Cancer Res 1989; 49: 7041–7044
   PubMed Web of Science ®Google Scholar
• Wondergem J, Strebel FR, Siddik ZH, Newman RA, Bull JM. The effects of anaesthetics on cisplatinum-induced toxicity at normal temperatures and during whole body hyperthermia: The influence of NaCl concentration of the vehicle. Int J Hyperthermia 1988; 4: 643–654
   PubMed Web of Science ®Google Scholar
• Lord PF, Kapp DS, Morrow D. Increased skeletal metastases of spontaneous canine osteosarcoma after fractionated systemic hyperthermia and local X-irradiation. Cancer Res 1981; 41: 4331–4334
   PubMed Web of Science ®Google Scholar
• Wondergem J, Siddik ZH, Strebel FR, Bull JM. Effect of whole body hyperthermia on cis-diamminedichloroplatinum (II)-induced antitumour activity and tissue Pt-distribution: Do anaesthetics influence the therapeutic ratio?. Eur J Cancer 1993; 29A: 549–554
   PubMed Web of Science ®Google Scholar
• Shwartz M, Pliskin JS, Grondahl HG, Boffa J. Use of the Kaplan-Meier estimate to reduce biases in estimating the rate of caries progression. Community Dent Oral Epidemiol 1984; 12: 103–108
   PubMed Web of Science ®Google Scholar
• Peschke P, Heimburg S, Wolber G, Zuna I, Hahn EW. Improved therapeutic response by distinct timing of multiple heat treatments during interstitial radiation in the Dunning R3327 prostate tumor model. J Cancer Res Clin Oncol 1998; 124: 172–178
   PubMed Web of Science ®Google Scholar
• Baker DG, Sager H, Constable WC, Goodchild NT. Influence of ultrasound-induced hyperthermia and X-irradiation on the incidence of metastases from a solid tumor. Invasion Metastasis 1984; 4: 111–124
   PubMedGoogle Scholar
• Kampinga HH. Cell biological effects of hyperthermia alone or combined with radiation or drugs: A short introduction to newcomers in the field. Int J Hyperthermia 2006; 22: 191–196
   PubMed Web of Science ®Google Scholar
• Peschke P, Hahn EW, Wenz F, Lohr F, Braunschweig F, Wolber G, Zuna I, Wannenmacher M. Differential sensitivity of three sublines of the rat Dunning prostate tumor system R3327 to radiation and/or local tumor hyperthermia. Radiat Res 1998; 150: 423–430
   PubMed Web of Science ®Google Scholar
• Wondergem J, Bulger RE, Strebel FR, Newman RA, Travis EL, Stephens LC, Bull JM. Effect of cis-diamminedichloroplatinum(II) combined with whole body hyperthermia on renal injury. Cancer Res 1988; 48: 440–446
   PubMed Web of Science ®Google Scholar
• Wondergem J, Strebel FR, Stephens LC, Siddik ZH, Bull JM. Chronic effect of whole body hyperthermia combined simultaneously with cis-diamminedichloroplatinum (II) on normal tissue in rat. Int J Hyperthermia 1995; 11: 37–47
   PubMed Web of Science ®Google Scholar
• Wondergem J, Bulger RE, Siddik ZH, Leygraaf JW, Strebel FR, Alonso M, Travis EL, Bull JM. A comparison of thermal enhancement of cis-diamminedichloroplatinum (II) induced renal and intestinal toxicities by whole body hyperthermia in the rat. Int J Radiat Oncol Biol Phys 1989; 16: 1551–1556
   PubMed Web of Science ®Google Scholar
• Toyota N, Strebel FR, Stephens LC, Matsuda H, Bull JM. Long-duration, mild whole body hyperthermia with cisplatin: Tumour response and kinetics of apoptosis and necrosis in a metastatic rat mammary adenocarcinoma. Int J Hyperthermia 1997; 13: 497–506
   PubMed Web of Science ®Google Scholar
• Richel O, Zum Vörde Sive Vörding PJ, Rietbroek R, Van der Velden J, Van Dijk JD, Schilthuis MS, Westermann AM. Phase II study of carboplatin and whole body hyperthermia (WBH) in recurrent and metastatic cervical cancer. Gynecol Oncol 2004; 95: 680–685
   PubMed Web of Science ®Google Scholar
• Ohno S, Siddik ZH, Baba H, Stephens LC, Strebel FR, Wondergem J, Khokhar AR, Bull JM. Effect of carboplatin combined with whole body hyperthermia on normal tissue and tumor in rats. Cancer Res 1991; 51: 2994–3000
   PubMed Web of Science ®Google Scholar
• Cohen JD, Robins HI, Tapazoglou E, Schmitt CL, Sapareto SA, Khatana A. Whole body hyperthermia and carboplatin: cytotoxicity for murin leukaemia and normal marrow. Br J Cancer 1991; 64: 528–30
   PubMed Web of Science ®Google Scholar
• Baba H, Maehara Y, Takeuchi H, Inutsuka S, Sugimachi K. Optimal scheduling increases therapeutic gain of adriamycin combined with hyperthermia. Anticancer Res 1993; 13: 651–654
   PubMed Web of Science ®Google Scholar
• Wondergem J, Stephens LC, Strebel FR, Baba H, Ohno S, Siddik ZH, Newman RA, Bull JM. Effect of adriamycin combined with whole body hyperthermia on tumor and normal tissues. Cancer Res 1991; 51: 3559–3567
   PubMed Web of Science ®Google Scholar
• Kong G, Braun RD, Dewhirst MW. Hyperthermia enables tumor-specific nanoparticle delivery: Effect of particle size. Cancer Res 2000; 60: 4440–4445
   PubMed Web of Science ®Google Scholar
• Kong G, Braun RD, Dewhirst MW. Characterization of the effect of hyperthermia on nanoparticle extravasation from tumor vasculature. Cancer Res 2001; 61: 3027–3032
   PubMed Web of Science ®Google Scholar
• Sakaguchi Y, Stephens L, Danhauser L, Makino M, Strebel FR, Jenkins GN, Bull JMC. Enhancement of antitumor effect and induction of apoptosis by a combination of 5-fluorouracil and whole body hyperthermia in rats. Proc Amer Assoc Cancer Res 1993; 34: 361, (Abstract 215)
   Google Scholar
• Haveman J, Rietbroek RC, Geerdink A, van Rijn J, Bakker PJl. Effect of hyperthermia on the cytotoxicity of 2',2'-difluorodeoxycytidine (gemcitabine) in cultured SW1573 cells. Int J Cancer 1995; 62: 627–630
   PubMed Web of Science ®Google Scholar
• Mohamed F, Marchettini P, Stuart OA, Urano M, Sugarbaker PH. Thermal enhancement of new chemotherapeutic agents at moderate hyperthermia. Ann Surg Oncol 2003; 10: 463
   PubMed Web of Science ®Google Scholar
• Katschinski DM, Jacobson EL, Wiedemann GJ, Robins HI. Modulation of VP-16 cytotoxicity by carboplatin and 41.8°C hyperthermia. J Cancer Res Clin Oncol 2001; 127: 425–432
   PubMed Web of Science ®Google Scholar
• Strebel FR, Sumiyoshi K, Jenkins GN, Rowe RW, Bull JMC. Drug sequence effect on therapeutic outcome (tumor growth, toxicity, and survival) of Irinotecan combined with Epirubicin in the in vivo MTLn3 rat mammary adenocarcinoma. Proc Amer Assoc Cancer Res 2002; 43: 587
   Google Scholar
• Vertrees RA, Das GC, Popov VL, Coscio AM, Goodwin TJ, Legrono R, Zwischenberger JB, Boor PJ. Synergistic interaction of hyperthermia and gemcitabine in lung cancer. Cancer Biol Ther 2005; 4: 1144–1153
   PubMed Web of Science ®Google Scholar
• Van Moorsel CJ, Pinedo HM, Smid K, Comijn EM, Voorn DA, Veerman G, Lakerveld B, Van der Vijgh WJ, Giaccone G, Postmus PE, Peters GJ. Schedule-dependent pharmacodynamic effects of gemcitabine and cisplatin in mice bearing Lewis lung murine non-small cell lung tumours. Eur J Cancer 2000; 36: 2420–2429
   PubMed Web of Science ®Google Scholar
• Kroep JR, Peters GJ, van Moorsel CJA, Catik A, Vermorken JB, Pinedo HM, van Groeningen CJ. Gemcitabine–cisplatin: A schedule finding study. Annals of Oncology 1999; 10: 1503–1510
   PubMed Web of Science ®Google Scholar
• Ostberg JR, Repasky EA. Emerging evidence indicates that physiologically relevant thermal stress regulates dendritic cell function. Cancer Immunol Immunother 2005; 55: 292–298
   PubMed Web of Science ®Google Scholar
• Milani V, Noessner E. Effects of thermal stress on tumor antigenicity and recognition by immune effector cells. Cancer Immunol Immunother 2005; 55: 312–319
   PubMed Web of Science ®Google Scholar